Therapeutic hypothermia for acute brain injuries

Area of Science:

• Neuroscience
• Critical Care Medicine
• Neurological Injury

Background:

• Therapeutic hypothermia, now known as target temperature management (TTM), has a 75-year history supporting its neuroprotective value.
• Hypothermia offers tissue-specific benefits including reduced excitotoxicity, inflammation, and free radical production, crucial for brain injury.
• Mild hypothermia (33°C) is standard for post-resuscitation and perinatal asphyxia, with growing evidence for other neurological injuries.

Purpose of the Study:

• To review the basic and clinical evidence for TTM in acute brain injury beyond cardiac arrest.
• To discuss TTM's application in ischemic stroke, hemorrhagic stroke, subarachnoid hemorrhage, and traumatic brain injury.
• To provide historical perspectives, technical overviews, and pathophysiological insights into TTM.

Main Methods:

• Review of historical data and scientific literature on therapeutic hypothermia.
• Analysis of clinical evidence supporting TTM for various acute brain injuries.
• Inclusion of clinical experience with endovascular hypothermia for acute brain injury management.

Main Results:

• TTM demonstrates significant neuroprotective effects by modulating cellular metabolism and inflammatory pathways.
• Evidence supports TTM's efficacy in conditions like stroke and traumatic brain injury, extending its application.
• Endovascular hypothermia is presented as a viable management technique for acute brain injuries.

Conclusions:

• TTM is a critical neuroprotective strategy for acute brain injury, with expanding indications.
• Further research and clinical application of TTM are warranted for stroke, subarachnoid hemorrhage, and TBI.
• TTM protocols and endovascular techniques are evolving for optimal patient outcomes in critical care.